Geratherm Medical AG (ETR:GME)
Germany · Delayed Price · Currency is EUR 2.670
+0.020 (0.75%)
Aug 5, 2026, 5:35 PM CET
Geratherm Medical AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 14 | 16 | 19 | 29 | 27 | 41 | |
Market Cap Growth | -14.97% | -17.46% | -35.56% | 7.56% | -34.50% | -23.12% |
Enterprise Value | 7.45 | 10.21 | 12.27 | 28.99 | 25.47 | 43.98 |
Last Close Price | 2.67 | 2.89 | 3.48 | 5.40 | 4.99 | 8.38 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 26.77 | 25.71 | 26.26 | 419.00 |
Forward PE | 133.50 | 82.57 | 87.00 | 19.64 | 55.43 | 20.31 |
PS Ratio | 0.94 | 0.98 | 1.01 | 1.14 | 0.98 | 1.60 |
PB Ratio | 0.74 | 0.79 | 0.90 | 1.31 | 1.22 | 2.24 |
P/TBV Ratio | 0.81 | 0.87 | 0.97 | 1.65 | 1.50 | 2.89 |
P/FCF Ratio | 12.65 | 13.61 | 11.25 | 40.93 | 42.26 | 231737.00 |
P/OCF Ratio | 11.08 | 11.92 | 10.09 | 19.85 | 9.76 | 45235.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.49 | 0.64 | 0.66 | 1.13 | 0.92 | 1.70 |
EV/EBITDA Ratio | 4.08 | 4.27 | 2.33 | 6.27 | 6.19 | 74.36 |
EV/EBIT Ratio | 11.14 | 8.30 | 3.60 | 9.99 | 9.66 | 74.58 |
EV/FCF Ratio | 6.53 | 8.94 | 7.33 | 40.60 | 39.61 | 245708.00 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.13 | 0.13 | 0.16 | 0.32 | 0.42 | 0.46 |
Debt / EBITDA Ratio | 1.36 | 1.04 | 0.62 | 1.56 | 2.26 | 14.98 |
Debt / FCF Ratio | 2.17 | 2.17 | 1.96 | 10.13 | 14.46 | 49507.01 |
Net Debt / Equity Ratio | -0.26 | -0.26 | -0.30 | -0.02 | -0.07 | 0.13 |
Net Debt / EBITDA Ratio | -2.81 | -2.15 | -1.21 | -0.11 | -0.39 | 4.04 |
Net Debt / FCF Ratio | -4.49 | -4.49 | -3.80 | -0.72 | -2.47 | 13360.78 |
Asset Turnover | 0.58 | 0.58 | 0.58 | 0.69 | 0.76 | 0.73 |
Inventory Turnover | 1.09 | 1.09 | 0.77 | 0.94 | 1.25 | 1.19 |
Quick Ratio | 2.81 | 2.81 | 3.33 | 2.52 | 3.16 | 1.25 |
Current Ratio | 5.20 | 5.20 | 5.65 | 5.51 | 5.02 | 2.33 |
Return on Equity (ROE) | -4.11% | -4.11% | 3.01% | 7.43% | 5.30% | 1.73% |
Return on Assets (ROA) | 1.83% | 5.92% | 9.42% | 5.65% | 4.57% | 1.81% |
Return on Invested Capital (ROIC) | 3.48% | 11.21% | 16.56% | 9.79% | 8.00% | 3.14% |
Return on Capital Employed (ROCE) | 2.78% | 5.11% | 11.91% | 8.84% | 8.81% | 2.17% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | 3.74% | 3.89% | 3.81% | 0.24% |
FCF Yield | 7.90% | 7.35% | 8.89% | 2.44% | 2.37% | 0.00% |
Dividend Yield | 3.77% | 3.46% | 2.87% | 2.78% | 2.40% | 0.00% |
Payout Ratio | - | -66.06% | 76.72% | 73.17% | 63.80% | 1.62% |
Buyback Yield / Dilution | - | 0.00% | 0.00% | 0.61% | -10.00% | 0.00% |
Total Shareholder Return | 3.77% | 3.46% | 2.87% | 3.39% | -7.60% | 0.00% |